The clinical relevance of filaggrin mutations: Effect on allergic disease
Annals of Allergy, Asthma & Immunology
November 2016 Volume 117, Issue 5, Pages 483-489 CME Review
Accreditation: The American College of Allergy, Asthma & Immunology (ACAAI) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Designation: The American College of Allergy, Asthma & Immunology (ACAAI) designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Planning Committee Members:
Mark W. Tenn, MD, BHSc (Author)
Anne K. Ellis, MD, MSc, FRCPC (Author)
Jonathan A. Bernstein, MD (CME Subcommittee)
Guha Krishnaswamy, MD (CME Subcommittee)
Mitchell H. Grayson, MD (CME Series Editor, Deputy Editor)
Gailen D. Marshall, Jr, MD, PhD (Editor-in-Chief)
Target Audience
Physicians involved in providing patient care in the field of allergy/asthma/immunology
Learning Objectives
At the conclusion of this activity, participants should be able to:
Describe the role of filaggrin in the maintenance of skin barrier function
Discuss how filaggrin null mutations can augment the risk of developing allergic diseases
Available Credit
- 1.00 AMA PRA Category 1 Credit™
- 1.00 Attendance